Adjuvant procarbazine, CCNU and vincristine chemotherapy in patients with highly anaplastic oligodendroglioma (in collaboration with the EORTC).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Lomustine; Procarbazine; Vincristine
- Indications Astrocytoma; Glioma
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 31 May 2013 Results of a pharmacogenomic analysis (n=115) presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 15 Oct 2012 Long-term follow-up results (median 140 months) published in the Journal of Clinical Oncology.
- 15 Oct 2012 Primary endpoint 'Overall-survival-duration' has been met according to long-term analysis of results published in the Journal of Clinical Oncology.